Nipple-sparing mastectomy for early breast cancer: the importance of intraoperative evaluation of retroareolar margins and intra-nipple duct removal

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBL CO
Citação
GLAND SURGERY, v.9, n.3, p.637-646, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Nipple-sparing mastectomy (NSM) is increasingly performed for breast cancer (BC) treatment. To ensure local control with this procedure, it is important to obtain clear surgical margins. Here, we aimed to estimate the confidence in intraoperative evaluation of the retroareolar margin (IERM) and the necessity of removing the intra-nipple ducts. Methods: In this retrospective cohort study, we evaluated 224 BC (infiltrating carcinoma 178, ductal carcinoma in situ 46) patients, who underwent NSM. IERM was determined via cytology and frozen sections. Following gland removal, the intra-nipple ducts were excised and embedded in paraffin for analysis. The retroareolar tissue was also paraffin-embedded and reanalyzed for definitive evaluation of retroareolar margins (DERM). The IERM predictive capacity in relation to DERM and the frequency of intra-nipple duct involvement were estimated. Results: IERM classified the sub-nipple areolar complex area as cancer-free in 219 cases (97.8%). The condition of clear retroareolar margin was confirmed by DERM in 216 cases (98.6%). The IERM accuracy was estimated as 98.6%. Ductal carcinoma in situ was detected in intra-nipple ducts using paraffin sections in 1.8% of the cases, despite dear IERM (4/219). Conclusions: In conclusion, IERM affords high accuracy and its results are suitable to manage the nipple-areolar complex. Nevertheless, some patients may retain residual disease in the intra-nipple ducts; thus, these ducts should ideally be removed during NSM.
Palavras-chave
Breast cancer (BC), nipple-sparing mastectomy (NSM), surgical margins, nipple ducts
Referências
  1. Alperovich M, 2016, BREAST J, V22, P18, DOI 10.1111/tbj.12517
  2. Amara D, 2015, ANN SURG ONCOL, V22, P3803, DOI 10.1245/s10434-015-4646-5
  3. Bartholomew AJ, 2019, ANN SURG ONCOL, V26, P2768, DOI 10.1245/s10434-019-07418-4
  4. Benediktsson KP, 2008, EJSO-EUR J SURG ONC, V34, P143, DOI 10.1016/j.ejso.2007.06.010
  5. Benson JR, 2016, GLAND SURG, V5, P37, DOI 10.3978/j.issn.2227-684X.2015.05.13
  6. Brachtel EF, 2009, J CLIN ONCOL, V27, P4948, DOI 10.1200/JCO.2008.20.8785
  7. Cont NT, 2017, BREAST CANCER RES TR, V165, P85, DOI 10.1007/s10549-017-4312-7
  8. Coopey SB, 2015, ANN SURG ONCOL, V22, P3764, DOI 10.1245/s10434-015-4648-3
  9. Crowe JP, 2008, ARCH SURG-CHICAGO, V143, P1106, DOI 10.1001/archsurg.143.11.1106
  10. de Alcantara P, 2011, ANN SURG ONCOL, V18, P3117, DOI 10.1245/s10434-011-1974-y
  11. DINNER MI, 1981, PLAST RECONSTR SURG, V68, P505, DOI 10.1097/00006534-198110000-00004
  12. Duarte GM, 2015, BREAST CANCER RES TR, V153, P557, DOI 10.1007/s10549-015-3568-z
  13. Frey JD, 2019, PLAST RECONSTR SURG, V143, P1575, DOI 10.1097/PRS.0000000000005600
  14. GENTIL F, 1980, J SURG ONCOL, V14, P173, DOI 10.1002/jso.2930140211
  15. Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f
  16. Giannotti DG, 2018, INT J RADIAT ONCOL, V102, P82, DOI 10.1016/j.ijrobp.2018.05.023
  17. Luo D, 2010, OCHSNER J, V10, P188
  18. Machida Y, 2018, BREAST CANCER-TOKYO, V25, P456, DOI 10.1007/s12282-018-0845-9
  19. Mallon P, 2013, PLAST RECONSTR SURG, V131, P969, DOI 10.1097/PRS.0b013e3182865a3c
  20. Mariscotti G, 2018, CLIN RADIOL, V73, P735, DOI 10.1016/j.crad.2018.03.008
  21. Marta GN, 2017, EJSO-EUR J SURG ONC, V43, P2036, DOI 10.1016/j.ejso.2017.09.014
  22. Mitchell SD, 2018, GLAND SURG, V7, P247, DOI 10.21037/gs.2017.09.10
  23. Piato JRM, 2015, EJSO-EUR J SURG ONC, V41, P986, DOI 10.1016/j.ejso.2015.04.019
  24. Piato JRM, 2016, AM J ROENTGENOL, V206, P1124, DOI 10.2214/AJR.15.15187
  25. Orzalesi L, 2016, BREAST, V25, P75, DOI 10.1016/j.breast.2015.10.010
  26. Papassotiropoulos B, 2019, ANN SURG ONCOL, V26, P1254, DOI 10.1245/s10434-019-07259-1
  27. Petit JY, 2009, BREAST CANCER RES TR, V117, P333, DOI 10.1007/s10549-008-0304-y
  28. Rusby JE, 2007, AM J SURG, V194, P433, DOI 10.1016/j.amjsurg.2007.06.019
  29. de Barros ACSD, 2019, SAO PAULO MED J, V137, P336, DOI 10.1590/1516-3180.2018.0356220719
  30. Smith Barbara L, 2018, Adv Surg, V52, P113, DOI 10.1016/j.yasu.2018.03.008
  31. Smith BL, 2017, J AM COLL SURGEONS, V225, P361, DOI 10.1016/j.jamcollsurg.2017.06.013
  32. Tang R, 2016, J AM COLL SURGEONS, V222, P1149, DOI 10.1016/j.jamcollsurg.2016.02.016
  33. Tramm T, 2011, INT J SURG PATHOL, V19, P817, DOI 10.1177/1066896909339737
  34. Wang M, 2019, AM SURGEON, V85, P768
  35. Wei CH, 2016, BREAST J, V22, P10, DOI 10.1111/tbj.12542
  36. Wu ZY, 2019, JAMA SURG, V154, P1030, DOI 10.1001/jamasurg.2019.2959
  37. Young WA, 2019, ANN SURG ONCOL, V26, P3115, DOI 10.1245/s10434-019-07560-z